DEADLINE ALERT for ABBV, MYPS, SDIG, LICY: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
April 28, 2022 11:00 ET
|
Law Offices of Howard G. Smith
BENSALEM, Pa., April 28, 2022 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
ABBVIE INC. (NYSE: ABBV) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against AbbVie Inc. (NYSE: ABBV)
April 28, 2022 00:30 ET
|
Bernstein Liebhard LLP
Did you lose money on investments in AbbVie? If so, please visit AbbVie Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or pallocco@bernlieb.com to discuss your...
ABBV SHAREHOLDER ALERT: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages AbbVie Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – ABBV
April 24, 2022 13:45 ET
|
The Rosen Law Firm PA
NEW YORK, April 24, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of AbbVie Inc. (NYSE: ABBV) between April 30, 2021 and...
DEADLINE ALERT for ABBV, MYPS, SDIG: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
April 22, 2022 12:00 ET
|
Law Offices of Howard G. Smith
BENSALEM, Pa., April 22, 2022 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
ABBV LOSS ALERT: ROSEN, SKILLED INVESTOR COUNSEL, Encourages AbbVie Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – ABBV
April 20, 2022 10:28 ET
|
The Rosen Law Firm PA
NEW YORK, April 20, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of AbbVie Inc. (NYSE: ABBV) between April 30, 2021 and...
DEADLINE ALERT for GWGH, ABBV, MYPS, and SDIG: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
April 18, 2022 15:00 ET
|
The Law Offices of Frank R. Cruz
LOS ANGELES, April 18, 2022 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
ROSEN, A LEADING, LONGSTANDING, AND TOP RANKED FIRM, Encourages AbbVie Inc. Investors with Losses Over $100K to Secure Counsel Before Important Deadline in Securities Class Action – ABBV
April 16, 2022 11:00 ET
|
The Rosen Law Firm PA
NEW YORK, April 16, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of AbbVie Inc. (NYSE: ABBV) between April 30, 2021 and...
ROSEN, RESPECTED INVESTOR COUNSEL, Encourages AbbVie Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action – ABBV
April 09, 2022 15:06 ET
|
The Rosen Law Firm PA
NEW YORK, April 09, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of...
Harpoon Therapeutics and AbbVie Announce Licensing and Option Collaboration to Advance HPN217, Harpoon’s BCMA-Targeting TriTAC®, and Expand Existing Discovery Collaboration
November 21, 2019 04:00 ET
|
Harpoon Therapeutics; AbbVie Inc.
Harpoon grants AbbVie option to license worldwide rights to HPN217 (BCMA), a TriTAC for the treatment of multiple myeloma planned for IND filing this year Expanded TriTAC discovery collaboration...
DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AbbVie Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
November 20, 2018 12:37 ET
|
Schall Law
LOS ANGELES, Nov. 20, 2018 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against AbbVie Inc. (“AbbVie” or...